本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sionna Therapeutics

6.88
-1.3800-16.71%
盤後6.900.0204+0.30%19:58 EDT
成交量:246.24萬
成交額:1,747.55萬
市值:3.10億
市盈率:-3.17
高:8.00
開:7.87
低:6.85
收:8.26
52周最高:54.97
52周最低:4.01
股本:4,499.81萬
流通股本:1,672.55萬
量比:2.32
換手率:14.72%
股息:- -
股息率:- -
每股收益(TTM):-2.1683
每股收益(LYR):-1.8835
淨資產收益率:-32.34%
總資產收益率:-21.54%
市淨率:1.16
市盈率(LYR):-3.65

資料載入中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities